Hemant Surgical Industries Share Price | Hemant Surgical Industries Stock Screener
HSIL
Medical Equipment
Track Hemant Surgical Industries share price live with TickJournal's free stock screener.
Check HSIL 52-week high low for the annual price range and momentum.
Use the Hemant Surgical Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Hemant Surgical Industries Market Cap
₹559.73 Cr.
HSIL P/E Ratio (TTM)
-
Hemant Surgical Industries P/B Ratio
3.34
EPS (TTM)
₹15.39
Dividend Yield
-
Debt to Equity
0.49
HSIL 52 Week High
-
Hemant Surgical Industries 52 Week Low
-
Operating Margin
-
Profit Margin
-
HSIL Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹274.00
Total Equity
₹138.00
Hemant Surgical Industries Share Price Chart
Screen Hemant Surgical Industries share price with an interactive chart. Analyse HSIL price trends and volatility across different timeframes.
Hemant Surgical Industries Company Profile - Fundamental Screener
Screen Hemant Surgical Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for HSIL shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE0GYI01028
Hemant Surgical Industries Balance Sheet Screener
Screen HSIL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 |
|---|---|---|
| Assets | ||
| Total Assets | 274 | 148 |
| Current Assets | 192 | 89 |
| Fixed Assets | 54 | 40 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 4 | 24 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 138 | 63 |
| Share Capital | 13 | 10 |
| Reserves & Surplus | 125 | 53 |
Hemant Surgical Industries Income Statement Screener - Profit & Revenue Analysis
Screen Hemant Surgical Industries income statement and profit fundamentals.
Analyze HSIL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Hemant Surgical Industries share price evaluation.
| Item | None-None | 2026-March | 2025-March |
|---|---|---|---|
| Revenue | 0 | 232 | 112 |
| Expenses | 0 | 209 | 98 |
| EBITDA | 0 | 23 | 14 |
| Operating Profit % | 0.00% | 10.00% | 8.00% |
| Depreciation | 0 | 2 | 1 |
| Interest | 0 | 4 | 2 |
| Profit Before Tax | 0 | 24 | 11 |
| Tax | 0 | 4 | 2 |
| Net Profit | 0 | 19 | 8 |
| EPS | 0.00 | 15.39 | 7.70 |
Hemant Surgical Industries Cash Flow Screener - Liquidity Fundamentals
Screen HSIL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March |
|---|---|
| Operating Activities | 9 |
| Investing Activities | -30 |
| Financing Activities | 18 |
| Net Cash Flow | -4 |
Hemant Surgical Industries Shareholding Pattern Screener
See Hemant Surgical Industries shareholding pattern with promoter, FII, and DII holdings.
Check Hemant Surgical Industries promoter holding and ownership changes for HSIL on TickJournal.
| Item | 2026-May | 2026-Mar | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.83% | 52.83% | 58.90% | 58.90% | 73.56% | 73.56% | 73.56% | 73.56% |
| FII Holding | 0.14% | 0.14% | 0.15% | 0.15% | 0.39% | 0.00% | 0.00% | 0.00% |
| DII Holding | 19.94% | 9.62% | 10.81% | 10.81% | 1.11% | 1.13% | 1.97% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.61% | 22.61% | 23.22% | 23.17% | 20.87% | 20.24% | 20.64% | 17.47% |
| Other Holding | 4.49% | 14.80% | 6.91% | 6.97% | 4.06% | 5.07% | 3.82% | 8.97% |
| Shareholder Count | 948 | 948 | 758 | 748 | 1,229 | 1,248 | 1,229 | 722 |
Hemant Surgical Industries Share Dividend Screener - Share Yield Analysis
Check Hemant Surgical Industries dividend history with payout and yield data.
View Hemant Surgical Industries dividend details including ex-dates and amounts for HSIL stock.
Hemant Surgical Industries Stock Index Membership
See which indices include Hemant Surgical Industries stock.
Check HSIL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Hemant Surgical Industries Market Events Screener - Corporate Actions
Get Hemant Surgical Industries corporate actions including splits, bonuses, and buybacks.
Check Hemant Surgical Industries stock events that may affect HSIL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 21.31% | ||
| Annual General Meeting | NA | -3.74% | ||
| 2026-05-15 | 2026-05-15 | Quarterly Result Announcement | NA | 29.62% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-30 | 2025-08-30 | Extraordinary General Meeting | NA | 24.79% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -0.94% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -0.31% |
Hemant Surgical Industries Competitors Screener - Peer Comparison
Screen HSIL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 16,724 | 52.90 | 1,875 | 6.61% | 326 | 63.92 |
| Tarsons Products | 1,400 | 100.67 | 423 | 3.45% | 16 | 65.55 |
| Q-Line Biotech | 1,369 | 24.35 | 342 | 5.93% | 56 | 73.47 |
| Laxmi Dental | 1,238 | 42.88 | 272 | 12.00% | 22 | 52.90 |
| Osel Devices | 802 | 27.96 | 293 | 56.84% | 30 | 40.07 |
| Fabtech Technologies | 701 | 18.20 | 411 | 22.29% | 36 | 56.31 |
| Vasa Denticity | 657 | 66.90 | 279 | 10.97% | 10 | 41.01 |
| Hemant Surgical Industries | 560 | 30.69 | 232 | 107.34% | 19 | 55.91 |
| Prevest Denpro | 458 | 22.83 | 72 | 7.02% | 21 | 44.62 |
| Aprameya Engineering | 288 | 56.28 | 55 | -59.83% | 5 | 35.53 |
Hemant Surgical Industries Company Announcements - News Screener
Screen HSIL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-09 | Revised Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon USA | - |
| 2026-06-09 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-05-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-05-15 | Intimation Of Appointment Of Cost Auditor | - |
| 2026-05-15 | Intimation Of Appointment Of Internal Auditor | - |
| 2026-05-15 | Intimation Of Appointment Of Secretarial Auditor | - |
| 2026-05-15 | Audited Financial Results Of The Company For Half And Financial Year Ended March 31 2026 | - |
| 2026-05-15 | Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On Friday May 15 2026 | - |
| 2026-05-09 | Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For The Half Year And Financial Year Ended March 31 2026 | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-02 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | - |
| 2026-03-31 | Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon USA | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |